cefuroxime sodium
hospira nz ltd - cefuroxime sodium 789mg equivalent to 750 mg cefuroxime - powder for injection - 750 mg - active: cefuroxime sodium 789mg equivalent to 750 mg cefuroxime
cefuroxime multichem
multichem nz limited - cefuroxime sodium 802mg equivalent to cefuroxime 750 mg; - powder for injection - 750 mg - active: cefuroxime sodium 802mg equivalent to cefuroxime 750 mg - cefuroxime is a bactericidal cephalosporin antibiotic which is resistant to most ?-lactamases and is active against a wide range of gram-positive and gram-negative organisms. it is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. susceptibility to cefuroxime sodium will vary with geography and time and local susceptibility data should be consulted where available (see section 5.1). indications include - respiratory tract infections for example, acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections. - ear, nose and throat infections for example, sinusitis, tonsillitis, pharyngitis and otitis media. - urinary tract infections for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. - soft-tissue infections for example, cellulitis, erysipelas and wound infections. - bone and joint infections for example, osteomyelitis and septic arthritis. - obstetric and gynecological infections, pelvic inflammatory diseases. - gonorrhea particularly when penicillin is unsuitable. - other infections including septicemia, meningitis and peritonitis. - prophylaxis against infection in abdominal, pelvic, orthopedic, cardiac, pulmonary, esophageal and vascular surgery where there is increased risk from infection
cefuroxime injection, powder, for solution
wg critical care, llc - cefuroxime sodium (unii: r8a7m9my61) (cefuroxime - unii:o1r9fj93ed) - cefuroxime for injection, usp is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: - lower respiratory tract infections, including pneumonia, caused by streptococcus pneumoniae, haemophilus influenzae (including ampicillin-resistant strains), klebsiella spp., staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), streptococcus pyogenes , and escherichia coli . - urinary tract infections caused by escherichia coli and klebsiella spp. - skin and skin structure infections caused by staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), streptococcus pyogenes , escherichia coli, klebsiella spp., and enterobacter spp. - septicemia caused by staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), streptococcus pneumoniae, escherichia coli, haemophilus influenzae (including ampicillin-resistant strains), and klebsiella spp. - meningitis
cefuroxime for injection
viatris limited - cefuroxime sodium 1.578 g equivalent to 1.5 g cefuroxime; - powder for injection - 1.5 g - active: cefuroxime sodium 1.578 g equivalent to 1.5 g cefuroxime
cefuroxime for injection
viatris limited - cefuroxime sodium 263mg equivalent 250 mg cefuroxime - powder for injection - 250 mg - active: cefuroxime sodium 263mg equivalent 250 mg cefuroxime
zetagal powder for solution for injection 750mg/vialv
elpen pharmaceutical co. inc. 95 marathonos ave., 190 09 pikermi, attica, greece - cefuroxime - powder for solution for injection - cefuroxime 750 mg - antibacterials for systemic use
cefuroxime injection powder for solution
app pharmaceuticals, llc - cefuroxime (unii: o1r9fj93ed) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 750 mg
cefuroxime injection powder for solution
app pharmaceuticals, llc - cefuroxime (unii: o1r9fj93ed) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 7.5 g in 80 ml
zinacef 250 mg powder for solution for injection
glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - cefuroxime - powder for solution for injection - cefuroxime 250 milligram(s) - antibacterials for systemic use
zinacef 750 mg powder for solution for injection
glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - cefuroxime - powder for solution for injection - cefuroxime 750 milligram(s) - antibacterials for systemic use